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Retinitis pigmentosa (RP) and macular dystrophy (MD) are prevalent retinal degenerative diseases 35 
associated with gradual photoreceptor death. These diseases are often caused by genetic mutations that 36 
result in degeneration of the retina postnatally after it has fully developed. The Prominin-1 gene (Prom1) 37 
is a causative gene for RP and MD, and Prom1- knockout (KO) mice recapitulate key features of these 38 
diseases including light-dependent retinal degeneration and stenosis of retinal blood vessels. The 39 
mechanisms underlying progression of such degeneration have remained unknown, however. We here 40 
analysed early events associated with retinal degeneration in Prom1-KO mice. We found that 41 
photoreceptor cell death and glial cell activation occur between 2 and 3 weeks after birth. High-throughput 42 
analysis revealed that expression of the endothelin-2 gene (Edn2) was markedly up-regulated in the 43 
Prom1-deficient retina during this period. Expression of Edn2 was also induced by light stimulation in 44 
Prom1-KO mice that had been reared in the dark. Finally, treatment with endothelin receptor antagonists 45 
attenuated photoreceptor cell death, gliosis, and retinal vessel stenosis in Prom1-KO mice. Our findings 46 
suggest that inhibitors of endothelin signalling may delay the progression of RP and MD and therefore 47 
warrant further study as potential therapeutic agents for these diseases. 48 
 49 
Keywords 50 
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1. Introduction 52 
Both retinitis pigmentosa (RP) and macular dystrophy (MD) are inherited retinal disorders 53 
associated with progressive photoreceptor cell death [1]. These diseases have a combined prevalence of 1 54 
in 3000 to 4000 people worldwide. Initial symptoms include nyctalopia (night blindness) and visual field 55 
deficits, which are followed by loss of visual acuity and colour blindness and eventually by complete 56 
blindness. Although >60 genes encoding various types of protein - including membrane proteins, 57 
transcription factors, splicing regulators, and enzymes related to the visual cycle - have been implicated in 58 
RP and MD [1], these conditions remain incurable, with effective therapeutic strategies remaining to be 59 
established, and they have profound effects on the quality of life. 60 
The Prominin-1 gene (Prom1, also known as AC133, CD133, and RP41) encodes a pentaspan 61 
transmembrane glycoprotein that is expressed in photoreceptor cells of the retina as well as in kidney and 62 
testis [2]. Several mutations of Prom1 have been identified in individuals with RP or MD [3-5], with all 63 
such mutations resulting in amino acid substitutions or carboxyl-terminal truncations of the encoded 64 
protein. The mechanisms underlying RP and MD associated with Prom1 mutations have been investigated 65 
by studies of several lines of Prom1-knockout (KO) mice [5-7]. Although photoreceptor cells develop 66 
normally in these KO mice, they begin to degenerate after birth, resulting in a progressive loss of the outer 67 
nuclear layer (ONL) of the retina and recapitulation of the signs of RP and MD. The retinal vasculature 68 
also becomes attenuated with disease progression [7]. 69 
We previously showed that photoreceptor cells of the Prom1-KO mouse retina degenerate in 70 
response to light stimulation. Such mice reared in a completely dark setting thus manifested a marked 71 
delay in the loss of photoreceptor cells. We therefore suggested that the mutant retinal cells are 72 
hypersensitive to light stimulation and experience phototoxicity [6]. The visual cycle was also found to be 73 
impaired in the Prom1-KO cells, and treatment based on chemical compounds that modulate the visual 74 
cycle was found to mitigate the mutant phenotype [6]. 75 
The Prom1 protein localises to the connecting cilium and outer segment of both rod and cone 76 
photoreceptors [3]. Ultrastructural analysis revealed the structure of the outer segment to be severely 77 
disorganised in photoreceptor cells of Prom1-KO mice, whereas other photoreceptor components - 78 
including the inner segment, nucleus, and axon - remained largely intact [6, 7]. Biochemical analysis has 79 
shown that two tyrosine residues in the carboxyl-terminal region of Prom1 are phosphorylated by the 80 
tyrosine kinases Src and Fyn, although the physiological implications of such phosphorylation remain to 81 
be elucidated [8]. Prom1 has also been shown to interact with the p85 regulatory subunit of 82 
phosphatidylinositol 3-kinase (PI3K) and to be essential for both the self-renewal and tumourigenic 83 
capacity of glioma stem cells [9]. In addition, Prom1 has been detected in cilia, which are protrusive 84 
structures at the cell membrane and key signalling hubs [10], and to be essential for maximisation of 85 
Hedgehog signalling in neural stem cells [11]. We recently showed that Prom1 activates the small GTPase 86 
Rho and regulates chloride conductance triggered by intracellular calcium uptake [12]. 87 
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To characterise the mechanisms underlying the role of Prom1 dysfunction in retinal degeneration 88 
and thereby to provide insight into potential treatments for Prom1 mutation-associated RP and MD, we 89 
here investigated the initial manifestations of such degeneration. We analysed Prom1 expression as well 90 
as the ONL transition in Prom1-KO mice. We then performed a high-throughput expression analysis to 91 
identify genes responsible for degeneration of the Prom1-deficient retina. Our results implicated an 92 
inflammatory pathway dependent on the endothelin 2 gene (Edn2), and we found that a chemical 93 
treatment targeted to endothelin signalling mitigated the deterioration of retinal structure and function in 94 
Prom1-KO mice.  95 
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2. Methods 97 
2.1. Mice 98 
Prom1-KO mice were established previously (CDB0623K, http://www2.clst.riken.jp/arg/methods.html), 99 
and they were reared on a hybrid genetic background of C57BL/6 and CBA/NSlc strains. The targeting 100 
vector for Prom1 ablation contained the lacZ (β-galactosidase) gene, with the result that expression of this 101 
latter gene reflects that of Prom1. Both the Prom1-KO mice and their wild-type (WT) littermates were 102 
kept on a 12-hour-light, 12-hour-dark cycle, with the cage racks being covered with blackout curtains and 103 
all procedures including feeding and cage maintenance being performed in the absence of light (<0.5 lux) 104 
during the dark phase. For experiments involving light stimulation, mice were exposed for 3 h to a light 105 
panel (LED viewer 5000; Shinko, Tokyo, Japan) placed on top of the cage, which resulted in a light 106 
intensity of 3800 lux at the bottom of the cage. For chemical treatment, mice received intraperitoneal 107 
injections (2 mg/kg) of each of the endothelin receptor antagonists BQ-123 (ab141005, Abcam) and BQ-108 
788 (ab144504, Abcam) on postnatal day (P) 14, P19, and P24. The mice were then subjected to analysis 109 
on P28. 110 
 111 
2.2. RNA extraction and RT-qPCR analysis 112 
The retina, retinal pigment epithelium (RPE), and testis were dissected from mice killed by cervical 113 
dislocation. Total RNA was extracted from the isolated tissue and was subjected to reverse transcription 114 
(RT) with the use of a NucleoSpin RNA extraction kit (U955C, Takara) and PrimeScript RT reagent kit 115 
(RR037, Takara), respectively. The resulting cDNA was subjected to quantitative polymerase chain 116 
reaction (qPCR) analysis with a CFX qPCR machine (Bio-Rad) and with primers listed in supplementary 117 
table S1. The amplification data were analysed with the comparative Ct method, and gene expression 118 
levels were normalised by that of the glyceraldehyde-3-phosphate dehydrogenase gene (Gapdh). 119 
 120 
2.3. High-throughput expression analysis 121 
Total RNA samples were prepared from three (P14) or four (P21) retinas of WT or Prom1-KO mice and 122 
were used to synthesise cDNA libraries with a TruSeq stranded-mRNA library preparation kit (Illumina, 123 
20020594). The libraries were sequenced with the NextSeq 500 platform (Illumina). In total, 124 
approximately twenty million reads/sample were mapped with the CLC genomics workbench software 125 
(Qiagen) [13]. The sequencing data were deposited in the DNA Data Bank of Japan (DDBJ) public 126 
database, with the accession number of SSUB016168. Gene ontology (GO) term analysis was performed 127 
according to the Kyoto Encyclopaedia of Genes and Genomes database (KEGG, 128 
https://www.genome.jp/kegg). 129 
 130 
2.4. Immunofluorescence analysis, β-galactosidase and isolectin staining, and TUNEL analysis 131 
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For immunofluorescence analysis, the enucleated retina was fixed for 2 h with a mixture of 1% 132 
paraformaldehyde and 0.2% glutaraldehyde in phosphate-buffered saline (PBS), incubated overnight in 133 
PBS containing 15% sucrose, embedded in O.C.T. compound (Sakura), and sectioned at a thickness of 12 134 
µm. The sections were exposed to mouse monoclonal antibodies to GFAP (G3893; Sigma) or rabbit 135 
polyclonal antibodies to Iba-1 (019-19741; Wako), and immune complexes were detected with Cy3-136 
conjugated secondary antibodies (715-166-151 and 715-166-152 for mouse and rabbit, respectively; 137 
Jackson Immunoresearch). Nuclei were counterstained with 4',6-diamidino-2-phenylindole (DAPI) with 138 
the use of DAPI Fluoromount-G (0100-20; Southern Biotech). Sections were also stained for β-139 
galactosidase (β-gal) activity with the use of a staining kit (11828673001, Roche). Apoptotic cells were 140 
detected by TUNEL analysis with digoxigenin-labelled dUTP (S7105, Merck Millipore), terminal 141 
deoxynucleotidyl transferase (3333566001, Merck), and rhodamine-conjugated antibodies to digoxigenin 142 
(11207750910, Roche). For preparation of flat-mount samples, the retina was fixed for 150 min with 4% 143 
paraformaldehyde and the RPE was peeled off. The samples were subjected to isolectin staining by 144 
consecutive exposure to 5% dried skim milk and Alexa Flour 488-conjugated GS-IB4 (I21411, Thermo 145 
Fisher Scientific) as described previously [14]. Images were acquired with an LSM 710 confocal 146 
microscope (Zeiss) for immunofluorescence, β-gal, and TUNEL staining, or with a BZ-X710 microscope 147 
(Keyence) for flat-mount preparations. Imaging data were processed and integrated with Photoshop 148 
(Adobe) and Illustrator (Adobe) software, respectively. 149 
 150 
2.5. Statistical analysis 151 
Quantitative data are presented as means ± s.e.m. Differences between two or among more than two 152 
groups were evaluated with the two-tailed Student’s t test and by one-way analysis of variance (ANOVA) 153 
followed by Tukey’s post hoc test, respectively. Statistical analysis was performed with Prism software 154 
(Graphpad), and a p value of <0.05 was considered statistically significant. 155 
  156 
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3. Results 157 
3.1. Prom1 is expressed in the retina from perinatal to adult stages 158 
We previously showed that retinal cells in Prom1-KO mice appear to develop normally before the onset of 159 
degeneration [6]. We here first examined the spatiotemporal expression of Prom1 in the mouse retina. 160 
Given that our Prom1-KO mice harbour the lacZ gene at the Prom1 locus, we performed staining for β-161 
gal activity in the heterozygous mutant mice at birth as well as at P2 (figure 1a-a”), P14 (figure 1b-b”), 162 
P21 (figure 1c-c”), and P42 (figure 1d-d”). At all the stages analysed, β-gal staining was localised 163 
predominantly to the outer layers in the retina, with more sporadic staining also apparent in the inner 164 
nuclear layer (INL). Given that retinal phenotypes of Prom1-KO mice are not obvious until 2 weeks after 165 
birth, these results suggested that Prom1 expression precedes the onset of function of the encoded protein 166 
in postnatal retinal homeostasis. 167 
 168 
3.2. The Prom1-KO mouse retina manifests both apoptosis and an inflammatory response at 3 169 
weeks after birth 170 
We previously showed that the retina of Prom1-KO mice appears normal at P14 and begins to 171 
degenerate soon after the animals first open their eyes at P14 [6]. We therefore investigated whether the 172 
Prom1-deficient retina might undergo apoptosis in response to light exposure. Whereas the TUNEL assay 173 
revealed few apoptotic cells in the retina of WT or Prom1-KO mice at P14 (figure 2a and b), a significant 174 
increase in the number of TUNEL-positive cells, located mainly in the ONL, was detected at P21 in the 175 
Prom1-KO retina (figure 2c–e). These results suggested that programmed cell death by apoptosis begins 176 
to occur in the ONL of the retina between 2 and 3 weeks after birth in Prom1-KO mice. 177 
Glial fibrillary acidic protein (GFAP) is an intermediate filament protein that is expressed by 178 
Müller glia in response to retinal injury [15, 16]. Similarly, Iba-1 is a scaffold protein that is expressed in 179 
microglia and which is up-regulated during an inflammatory response [17, 18]. We therefore next 180 
examined whether the Prom1-KO retina might undergo light-induced inflammation by analysing the 181 
expression of these two proteins. Immunofluorescence analysis revealed that, whereas both GFAP and 182 
Iba-1 were essentially undetectable in the WT or Prom1-KO retina at P14 (figure 2f–i), a marked increase 183 
in the extent of staining for both proteins was observed in the Prom1-KO retina at P21 (figure 2j–m), 184 
suggesting that the increased cell death that occurs in the ONL of the mutant mice after birth is 185 
accompanied by the activation of glial cells. 186 
 187 
3.3. Inflammation-related gene expression is up-regulated in the Prom1-KO mouse retina 188 
We next sought to identify genes whose expression might be affected by Prom1 deficiency by 189 
subjecting the retina of WT and Prom1-KO mice at P14 and P21 to high-throughput expression analysis 190 
based on RNA sequencing. Gene expression at P14 tended to vary within each genotype, and the only 191 
gene whose expression differed significantly between genotypes was Prom1 itself (figure 3a, 192 
supplementary table S2), suggesting that Prom1 does not significantly influence the gene expression 193 
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profile at P14. In contrast, the expression of various genes differed between the two genotypes at P21 194 
(figure 3b, supplementary table S3). The expression of 1,081 and 766 genes was thus up- and down-195 
regulated, respectively, in the Prom1-KO retina with a p value of <0.01. In particular, expression of Edn2 196 
was the most consistently and markedly up-regulated in the Prom1-KO retina. The expression of genes 197 
associated with the inflammatory response - such as Ifi44l, Serpina3n, S100a6, Bcl3, and Gfap - was also 198 
increased in the Prom1-KO retina at P21. Conversely, the expression of genes related to RP or of those 199 
essential for retinal development and functional homeostasis - including Fscn2 (RP30) [19], Prph2 (RP7) 200 
[20], Nr2e3 (RP37) [21], Kcnv2 [22], Elovl2 [23], Pde6b (RD1) [24], and Ttc21b [25] - was down-201 
regulated in the Prom1-KO retina at P21 (supplementary table S3). GO term analysis revealed that several 202 
signalling pathways, including apoptotic (TNF) and infectious-related signal (Epstein-Barr virus infection) 203 
signals, were affected by the loss of Prom1 (figure 3c). 204 
We also investigated whether the observed effects of Prom1 deficiency on gene expression were 205 
specific to the retina. Given that Prom1 is expressed in the retina, RPE, and testis [2], we performed RT-206 
qPCR analysis of RNA prepared from these tissues of WT and Prom1-KO mice at P21. Consistent, with 207 
the results of our RNA-sequencing analysis, the expression of Edn2, Bcl3, and Gfap was increased in the 208 
retina of Prom1-KO mice (figure 3d). However, the expression of these genes in the RPE and testis did 209 
not differ between the two genotypes, indicating that the effect of Prom1 on their expression is specific to 210 
the retina. Together, these various data suggested that Prom1 deficiency results in up-regulation of 211 
inflammation-related genes and down-regulation of genes essential for functional homeostasis of 212 
photoreceptor cells at 3 weeks after birth. 213 
 214 
3.4. Inflammation-related gene expression is increased by light stimulation in the Prom1-KO mouse 215 
retina 216 
To determine the mechanism underlying the up-regulation of specific gene expression apparent in the 217 
retina of Prom1-KO mice at P21, we examined whether light stimulation might play a role. We therefore 218 
compared such gene expression between P21 retinas obtained from Prom1-KO mice reared under a 219 
normal day-night cycle or in the dark. RT-qPCR analysis revealed that, whereas the expression of Edn2, 220 
Bcl3, and Gfap did not differ between Prom1-KO and WT mice reared in the dark condition, marked up-221 
regulation of the expression of each of these genes was apparent specifically in Prom1-KO mice raised 222 
under the normal day-night condition (figure 4a). Consistent with these results, immunofluorescence 223 
analysis showed that the number of GFAP-positive cells in the retina was smaller for Prom1-KO mice 224 
reared in the dark compared with those reared under the normal condition (figure 4b and c). To examine 225 
further the effect of light on gene expression, we maintained Prom1-KO mice and their WT littermates 226 
under the dark condition for 3 weeks, exposed them to a bright light for 3 h, and then allowed them to 227 
recover for 3 days in the dark. The retina was then dissected and subjected to RT-qPCR and 228 
immunofluorescence analyses. Light stimulation resulted in a marked increase both in the expression of 229 
Edn2 and Bcl3 (Figure 4d) and in the number of GFAP-positive cells (figure 4e) in the retina of Prom1-230 
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KO mice but not in that of WT mice. Collectively, these results thus suggested that the up-regulation of 231 
Edn2, Bcl3, and Gfap expression apparent in the retina of Prom1-KO mice is an immediate response to 232 
light stimulation, and that the inflammatory response mediated by these genes is one of the primary events 233 
leading to degeneration of the mutant retina. 234 
 235 
3.5. Endothelin receptor antagonists attenuate Gfap expression and gliosis in the Prom1-KO mouse 236 
retina 237 
Endothelin acts at specific receptors [26, 27] to increase both the number of GFAP-positive 238 
Müller cells [28] and retinal cell death [29]. Given the elevated expression of Edn2 and Gfap apparent in 239 
the retina of Prom1-KO mice, we hypothesised that Edn2 might induce aberrant proliferation of glial cells 240 
and GFAP expression in association with retinal degeneration in these animals. We therefore examined 241 
the possible effects of endothelin receptor antagonists in the mutant mice. 242 
 The drugs BQ-123 and BQ-788, which target endothelin receptors A and B, respectively [30], 243 
were both injected intraperitoneally into Prom1-KO mice at P14, P19, and P24, and the mice were 244 
analysed at P28. Whereas GFAP-positive cells were not observed in the retina of WT mice, they were 245 
detected in that of Prom1-KO mice treated with dimethyl sulphoxide (DMSO) vehicle (figure 5a and b). 246 
However, the number of GFAP-positive cells was markedly reduced in the mutant mice by treatment with 247 
BQ-123 and BQ-788 (figure 5c). Staining of retinal flat-mount preparations with fluorescently labelled 248 
isolectin to detect vascular endothelial cells also revealed fewer retinal vessels in Prom1-KO mice than in 249 
WT mice and that this difference was attenuated by treatment of the mutant animals with BQ-123 and BQ-250 
788 (figure 5d–g). 251 
RT-qPCR analysis showed that the expression of Edn2, Bcl3, and Gfap was increased in the retina 252 
of Prom1-KO mice at P28 compared with that in WT mice. Whereas the expression of Edn2 and Bcl3 in 253 
the mutant retina was not affected by treatment with BQ-123 and BQ-788, that of Gfap was significantly 254 
attenuated (figure 5h), suggesting that up-regulation of Gfap expression in the mutant retina is mediated 255 
by endothelin receptor signalling but that that of Edn2 and Bcl3 expression is not. 256 
Finally, we examined the effect of BQ-123 and BQ-788 treatment on the number of apoptotic 257 
cells in the retina of Prom1-KO mice. The TUNEL assay revealed that the marked increase in the number 258 
of such cells apparent in the mutant retina at P28 was significantly attenuated by administration of the two 259 
drugs (figure 5l), suggesting that endothelin receptor signalling contributes to loss of retinal cell 260 
homeostasis.  261 
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4. Discussion 262 
We have here described early manifestations of the retinal degeneration that occurs in Prom1-KO 263 
mice and identified related genes. We thus detected the aberrant presence of glial cells and the expression 264 
of genes associated with the inflammatory response in the mutant retina. Given that the expression of 265 
these genes was not activated in the retina of Prom1-KO mice maintained in the dark condition, this 266 
inflammatory response appears to be dependent on light stimulation. Finally, we found that the 267 
deterioration and gliosis characteristic of the mutant retina were ameliorated by the administration of 268 
endothelin receptor antagonists. 269 
Although we found that Prom1 is expressed in the retina from birth, the loss of Prom1 did not 270 
substantially affect the expression level of any gene in the retina at P14, suggesting that Prom1 may not 271 
play an essential role in the retina prior to light exposure. We previously showed by RT-qPCR analysis 272 
that the expression of both Rdh12 and Abca4, two genes that contribute to the visual cycle, was reduced in 273 
the retina of Prom1-KO mice compared with that of WT mice at P14 [6], suggesting that impairment of 274 
the visual cycle might lead to retinal degeneration. Although this result is reproducible as assayed by RT-275 
qPCR (supplementary figure S1), the difference in the expression level of each gene between the two 276 
genotypes was associated with a relatively high p value in the high-throughput expression analysis 277 
performed in the present study (figure 3, supplementary table 2), suggesting this decrease is not critical. 278 
 In contrast to the lack of an effect of Prom1 deficiency on the gene expression profile of the retina 279 
at P14, we detected many genes, including those related to the inflammatory response, as well as 280 
signalling pathways whose activity was altered in the Prom1-KO retina at P21. The expression of genes 281 
related to phototransduction, for example, was significantly down-regulated in the Prom1-KO retina at 282 
P21 (figure 3c, supplementary table S3), indicating that Prom1 may be essential for the transcription of 283 
such genes or may form a transcriptional network with them. Of note, we found that the expression of 284 
causal genes for RP was also down-regulated in the mutant retina at P21. 285 
 Of the genes whose expression was up-regulated in the Prom1-KO retina at P21, Edn2 showed the 286 
largest fold change. Edn2 encodes a secretory peptide that plays a role in a wide range of biological 287 
processes, including smooth muscle contraction and ovulation [31] as well as development of the enteric 288 
nervous system [32]. Its expression is also induced in association with the inflammatory response and 289 
promotes glial cell proliferation in the central nervous system [33]. Furthermore, consistent with the 290 
perturbation of the retinal vasculature in Prom1-KO mice apparent in both the present and a previous [7] 291 
study, Edn2 has been found to inhibit retinal vascular development [34]. On the other hand, it was also 292 
shown to promote photoreceptor cell survival [35]. These various observations suggest that the role of 293 
Edn2 in the photoreceptor degeneration associated with RP and MD is complex. 294 
The expression of Edn2 has also been shown to be up-regulated in other mouse models of RP [35], 295 
including retina-specific Cdhr1-KO mice [36], with Prom1 and Cdhr1 having been found to interact with 296 
each other [4]. In addition to Edn2, the other genes whose expression was affected in the Prom1-KO 297 
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mouse retina overlapped markedly with those affected in the conditional Cdhr1-KO mouse retina, 298 
suggesting that Prom1 and Cdhr1 may function in the same intracellular signalling pathways. 299 
 Although we found that the expression of Edn2 and Bcl3 in the Prom1-KO retina was induced by 300 
light stimulation, the mechanism underlying this effect remains unclear. Nevertheless, our study suggests 301 
the possibility that an imbalance in intracellular ions caused by the loss of Prom1 (given that Prom1 302 
regulates chloride conductance activated by intracellular calcium uptake [12]) may impair the function of 303 
cytoplasmic organelles such as mitochondria and the endoplasmic reticulum, and thereby elicit a stress 304 
response. Studies to identify the transcriptional regulatory elements of Edn2 and the corresponding 305 
transcription factors and upstream signalling pathways underlying its photoactivation are warranted. 306 
 Gliosis is a response to injury in the central nervous system and is associated with the appearance 307 
of GFAP-positive glial cells [26]. It is also a feature of certain neurodegenerative retinal diseases 308 
including RP [37], with gliosis in RP having been found to be related to several RP genes. Targeting of 309 
gliosis is therefore a potential clinical strategy to delay disease progression and ameliorate associated 310 
symptoms. We have now shown that administration of endothelin receptor antagonists attenuated both the 311 
appearance of GFAP-positive glial cells and vascular endothelial constriction in the retina of Prom1-KO 312 
mice. These findings indicate that blockade of endothelin signalling may be an effective clinical strategy 313 
for the treatment of gliosis. However, caution is warranted with such an approach for the treatment of RP, 314 
given the various functions of endothelins and the consequent potential for adverse systemic effects. 315 
Intravitreal injection of endothelin receptor antagonists may help to avoid such side effects. Gene therapy 316 
targeting endothelin receptor function is also a potential therapeutic approach for RP. Finally, replacement 317 
of dead tissue with functional cells through a regenerative medicine approach may be required for the 318 
successful treatment of RP and MD [38]. 319 
In conclusion, our results implicating up-regulation of Edn2 expression in the retinal pathology of 320 
Prom1-KO mice suggest that localized pharmacological targeting of endothelin receptor signalling 321 
warrants further investigation as a clinical intervention for the prevention or treatment of retinal 322 
degenerative diseases such as RP and MD.  323 
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Figure Legends 470 
Figure 1. Prom1 is expressed in the ONL of the retina from perinatal to adult stages. The retina of 471 
heterozygous Prom1 mutant mice at P2 (a-a”), P14, (b-b”), P21 (c-c”), and P42 (d-d”) was subjected to 472 
staining of β-gal activity (a,b,c,d) as well as to staining of nuclei with DAPI (a’,b’,c’,d’). Merged images 473 
are also shown (a”,b”,c”,d”). Data are representative of three retinas at each age. Scale bar in (a) is (50 474 
μm) and applies to all images. RPE, retinal pigment epithelium; NBL, neuroblast layer; GCL, ganglion 475 
cell layer; OS, outer segments; IS, inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; 476 
INL, inner nuclear layer; IPL, inner plexiform layer. 477 
 478 
Figure 2. Programmed cell death and an inflammatory response in the postnatal Prom1-KO mouse retina. 479 
(a–d”) TUNEL staining of the WT (a-a”,c-c”) and Prom1-KO (b-b”,d-d”) mouse retina at P14 (a-b”) 480 
and P21 (c-d”). Nuclei were stained with DAPI (a’,b’,c’,d’). Merged images of TUNEL (red) and DAPI 481 
(blue) staining are also shown (a”,b”,c”,d”). Arrowheads in (d,d”) indicate apoptotic cells. (e) 482 
Quantitation of the proportion of TUNEL-positive cells among all DAPI-stained cells for images similar 483 
to those in (a),(b),(c) and (d). Data are means ± s.e.m. for four retinas for each condition. ** p < 0.01; n.s., 484 
not significant (two-tailed Student’s t test). (f–m) Immunofluorescence staining for GFAP (f, h,j,l) and Iba-485 
1 (g,i,k,m) in the retina of WT (f,g,j,k) and Prom1-KO (h,i,l,m) mice at P14 (f–i) and P21 (j–m). Merged 486 
images with DAPI staining are also shown (f’,g’,h’,i’,j’,k’,l’,m’). Arrowheads in (m) indicate Iba-1–487 
positive cells. Data are representative of three (P14) or five (P21) retinas for each genotype. Scale bar in 488 
(a) is 50 µm and applies to all images. 489 
 490 
Figure 3. Effects of Prom1 deficiency on gene expression in the retina. (a,b) Volcano plots for RNA-491 
sequencing analysis of the retina of Prom1-KO mice relative to that of WT mice at P14 (a) and P21 (b). 492 
Genes with a p value of 1 × 10–10 are indicated with the blue arrowhead in (b). A cut-off p value of 1 × 10–493 
2 is indicated by the green dashed line. Data are for three (P14) or four (P21) retinas of each genotype. (c) 494 
GO term analysis based on KEGG pathways for genes whose expression differed significantly between 495 
the retinas of Prom1-KO and WT mice in the RNA-sequencing analysis at P21. (d) RT-qPCR analysis of 496 
Edn2, Bcl3, and Gfap expression in the retina, RPE, and testis of WT and Prom1-KO mice at P21. Data 497 
are means ± s.e.m. for three retinas of each genotype. *p < 0.05, **p < 0.01, n.s., not significant (two-498 
tailed Student’s t test). 499 
 500 
Figure 4. Genes whose expression is increased by Prom1 deficiency are up-regulated by light stimulation. 501 
(a) RT-qPCR analysis of Edn2, Bcl3, and Gfap expression in the P21 retina of WT or Prom1-KO mice 502 
that had been reared either under a normal day-night cycle or in the dark. Data are means ± s.e.m. for four 503 
retinas for each condition. *p < 0.05, **p < 0.01, n.s., not significant, versus WT/normal (one-way 504 
ANOVA followed by Tukey’s post hoc test). (b and c) Immunofluorescence analysis of GFAP expression 505 
in the retina of Prom1-KO mice raised as in (a). Merged images with DAPI staining are also shown. Scale 506 
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bar in (b) is 50 µm and applies to all images. Data are representative of four (dark) or seven (normal day-507 
night) retinas. (d) RT-qPCR analysis of Edn2 and Bcl3 expression in the retina of Prom1-KO and WT 508 
mice that had been reared in the dark condition for 3 weeks, exposed (or not) to a bright light for 3 h, and 509 
then allowed to recover in the dark for 3 days. Data are means ± s.e.m. for five retinas for each condition. 510 
*p < 0.05, n.s., not significant, versus WT/dark (one-way ANOVA followed by Tukey’s post hoc test). (e) 511 
Immunofluorescence analysis of GFAP expression in the retina of Prom1-KO mice raised in the dark and 512 
stimulated with light as in (d). Merged images with DAPI staining are also shown. Data are representative 513 
of three retinas. 514 
 515 
Figure 5. Endothelin receptor antagonists attenuate the increase in the number of GFAP-positive cells and 516 
vascular stenosis in the retina of Prom1-KO mice. (a–c) Immunofluorescence analysis of GFAP 517 
expression in the retina of WT (a) or Prom1-KO (b and c) mice treated with the combination of BQ-123 518 
and BQ-788 (c) or with DMSO vehicle (a and b) at P14, P19, and P24 and analysed at P28. Merged 519 
images with DAPI staining are also shown. Scale bar in (a), 50 µm. Data are representative of three retinas 520 
per condition. (d–f) Isolectin staining of the retina of mice as in (a) to (c). The boxed regions of the left 521 
panels are shown at higher magnification in the right panels. Scale bars, 100 μm. (g) Area of blood vessels 522 
measured in images similar to those in (d) to (f). Data are means + s.e.m. for X retinas per condition. *p < 523 
0.05, ****p < 0.0001 (one-way ANOVA followed by Tukey’s post hoc test). (h) RT-qPCR analysis of 524 
Edn2, Bcl3, and Gfap expression in the retina of the treated mice. Data are means ± s.e.m. for three retinas 525 
per condition. **p < 0.01, n.s., not significant (one-way ANOVA followed by Tukey’s post hoc test). (i–k) 526 
TUNEL staining for apoptotic cells in the retina of the treated mice. Merged images with DAPI staining 527 
are also shown. Scale bar in (i), 50 µm. (l) Number of apoptotic cells determined from images similar to 528 
those in (i) to (k). Data are means ± s.e.m. for three retinas per condition. **p < 0.01, ***p < 0.001 (one-529 
way ANOVA followed by Tukey’s post hoc test). 530 
 531 
Supplementary Figure 532 
Supplementary figure S1. Expression of Rdh12 and Abca4 is down-regulated in the retina of Prom1-KO 533 
mice at P14. 534 
 535 
Supplementary Tables 536 
Supplementary table S1. Primers used for this study. 537 
Supplementary table S2. RNA-sequencing analysis of the retina of Prom1-KO and WT mice at P14. 538 
Supplementary table S3. RNA-sequencing analysis of the retina of Prom1-KO and WT mice at P21. 539 
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